Vaccination

Homologous Pfizer-BioNTech booster safe for adolescents

For adolescents aged 12 to 17 years, reactions to homologous Pfizer-BioNTech booster vaccination occur with similar frequency as after receipt of the second vaccine dose, and they are generally mild to moderate in severity, ...

Vaccination

Pfizer asks FDA to allow COVID-19 vaccine for kids under 5

Pfizer on Tuesday asked the U.S. to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start receiving shots as early as March.

Vaccination

Pfizer booster more than 50% protective against omicron

A booster dose of the Pfizer–BioNTech vaccine (BNT162b2) against SARS-CoV-2 after an initial two doses of either the CoronaVac inactivated virus vaccine or Pfizer–BioNTech mRNA vaccine is shown to provide protection against ...

page 7 from 40